SSRI Antidepressant
Pregnancy: Avoid in late pregnancy; neonatal adaptation syndrome
Escitalopram
Brand names: Cipralex
Adult dose
Dose: 10 mg once daily
Route: Oral
Frequency: Once daily
Max: 10 mg/day in over 65s (MHRA restriction); 20 mg/day in standard adults
MHRA 2011: Maximum dose in over 65s is 10 mg/day due to QT prolongation risk
Paediatric dose
Dose: Seek specialist opinion N/A/kg
Route: Oral
Frequency: Seek specialist opinion
Max: Seek specialist opinion
Seek specialist opinion
Dose adjustments
Renal
No adjustment if eGFR above 30; use with caution if eGFR under 30
Hepatic
Halve dose in moderate-severe hepatic impairment
Paediatric weight-based calculator
Seek specialist opinion
Clinical pearls
- S-enantiomer of citalopram — slightly more potent (10 mg escitalopram approximately equivalent to 20 mg citalopram) but same QT concern applies
- MHRA 2011: Maximum 10 mg/day in over 65s — same rationale as citalopram dose restriction
- Excellent tolerability profile — fewer drug interactions than fluoxetine or paroxetine due to minimal CYP inhibition
- Evidence base for efficacy in late-life depression is strong — well-tolerated at restricted elderly dose
- Hyponatraemia monitoring essential in first month — risk shared with all SSRIs in elderly
Contraindications
- Concurrent MAOI use
- Congenital long QT syndrome
- Concurrent QT-prolonging drugs
Side effects
- Nausea
- QT prolongation (dose-dependent)
- Hyponatraemia
- Sexual dysfunction
- Insomnia or somnolence
- Increased bleeding risk
Interactions
- MAOIs (serotonin syndrome)
- QT-prolonging drugs (additive risk)
- NSAIDs / warfarin (bleeding)
- Cimetidine / omeprazole (increase levels via CYP2C19)
Monitoring
- ECG (QTc) before starting
- Sodium
- Mood and suicide risk
Reference: BNFc; BNF 90; MHRA Drug Safety Update 2011 (escitalopram QT); NICE CG90 (Depression); AGS Beers Criteria 2023. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5